CSIRO-founded Main Sequence Ventures has pocketed $194m for its second fund, which has added decarbonisation to the firm’s list of targeted technologies.
Main Sequence Ventures, the Australia-based venture capital firm founded by Commonwealth Scientific Research Organisation (CSIRO), secured A$250m ($194m) for its second fund yesterday.
Limited partners include aerospace and defence manufacturer Lockheed Martin, Singaporean state-owned investment firm Temasek, superannuation fund HostPlus, venture capital firm Horizons Ventures and unspecified family offices and individual investors represented by Morgan Stanley Wealth Management and Mutual Trust.
Main Sequence was founded in 2017 to manage CSIRO Innovation Fund 1, an investment vehicle established by CSIRO and the Australian federal government. The firm specialises in commercialising academic research and investing in spinouts.
It focuses on deep tech solving one of six key objectives – feeding 10 billion people, population-scale healthcare, industrial productivity, accessing space, enabling next-generation computing and decarbonisation.
Decarbonisation technologies is an added focus with Fund II and partner Martin Duursma will lead on this effort.
Mike Zimmerman, partner at Main Sequence, said: “Our first…
